Regulatory News Service

VALBIOTIS SA: Valbiotis presents the full results of the Phase II/III REVERSE-IT study: impressive efficacy of TOTUM•63 against prediabetes and the early stages of type 2 diabetes

Retrieved on: 
Saturday, September 16, 2023
Volunteering, Glycated hemoglobin, Partnership, American Diabetes Association, Diabetes, Marketing, Type 2 diabetes, International Diabetes Federation, Research and development, Development, Hypoglycemia, Patient, Metformin, Risk, Regulatory News Service, Ageing, Research, Phase, Prediabetes, Disease, Conditional sentence, Pharmaceutical industry, Salt, Dietary supplement

VALBIOTIS SA: Valbiotis presents the full results of the Phase II/III REVERSE-IT study: impressive efficacy of TOTUM•63 against prediabetes and the early stages of type 2 diabetes

Key Points: 
  • VALBIOTIS SA: Valbiotis presents the full results of the Phase II/III REVERSE-IT study: impressive efficacy of TOTUM•63 against prediabetes and the early stages of type 2 diabetes
    Dissemination of a French Regulatory News, transmitted by EQS Group.
  • With REVERSE-IT, TOTUM•63 now has unrivaled proof of efficacy for a non-drug health product against prediabetes and the untreated early stages of type 2 diabetes.
  • We also demonstrated a 40% reduction in the number of new diagnoses of type 2 diabetes among prediabetics.
  • Around 537 million adults (aged 20-79) live with diabetes worldwide, 90% of whom have type 2 diabetes, according to the International Diabetes Federation [1] .

Charwood Energy: H1 2023 revenue:

Retrieved on: 
Saturday, September 16, 2023
Farm, Regulatory News Service, ISIN, Plant, Heat, Biomass, ARR, Livestock, Rare-earth element, Renewable energy

Charwood Energy (ISIN code: FR001400AJ60, ticker: ALCWE), a French company specializing in custom solutions for recovering energy from biomass, posts its H1 2023 revenue.

Key Points: 
  • Charwood Energy (ISIN code: FR001400AJ60, ticker: ALCWE), a French company specializing in custom solutions for recovering energy from biomass, posts its H1 2023 revenue.
  • In H1 2023, Charwood Energy generated €1.5 million in revenue, compared to €2.1 million in H1 2022 [1] .
  • To date, the Group has recorded secured orders [3] on behalf of third parties totalling €3.7 million, deliverable and billable over 2023 and 2024.
  • Concerning business on its own behalf, the initial business plan continues with 5 plants under development as of June 30, 2023.

Kaufman & Broad SA: RELATED-PARTY TRANSACTION ENTERED INTO BETWEEN KAUFMAN & BROAD S.A. AND ARTIMUS PARTICIPATIONS

Retrieved on: 
Wednesday, September 6, 2023
Kaufman & Broad S.A., Sale, EUR, Regulatory News Service, Commercial code, Security (finance), Audit, Bank

Kaufman & Broad SA: RELATED-PARTY TRANSACTION ENTERED INTO BETWEEN KAUFMAN & BROAD S.A. AND ARTIMUS PARTICIPATIONS

Key Points: 
  • Kaufman & Broad SA: RELATED-PARTY TRANSACTION ENTERED INTO BETWEEN KAUFMAN & BROAD S.A. AND ARTIMUS PARTICIPATIONS
    Dissemination of a French Regulatory News, transmitted by EQS Group.
  • Related-party transaction entered into between Kaufman & Broad S.A. and Artimus Participations
    On 5 September 2023, the board of directors of Kaufman & Broad S.A. (the “Company”) approved [1] the signing of an agreement related to the buy-back of a block of 1,251,000 shares of the Company from Artimus Participations.
  • This transaction will result in all Company's shareholders benefiting from an accretive effect, without affecting the Company's investment capacity, while stabilizing the Company's shareholding.
  • Following the transaction and cancellation of the repurchased shares, Artimus Participations' stake in the Company will be reduced to 5.40 % of the Company's share capital and to 8.36 % of its voting rights.

Kaufman & Broad SA: REPURCHASE OF 5.93 % OF THE COMPANY'S SHARE CAPITAL FROM ARTIMUS PARTICIPATIONS

Retrieved on: 
Wednesday, September 6, 2023
KB Home, Regulatory News Service, Sale, Security (finance), Bank

Kaufman & Broad (the “Company”) announces that it has concluded on 5 September 2023, under its share buy-back program, a share purchase agreement on a block of 1,251,000 shares of the Company from Artimus Participations at a price of 25.92 euros per share, i.e.

Key Points: 
  • Kaufman & Broad (the “Company”) announces that it has concluded on 5 September 2023, under its share buy-back program, a share purchase agreement on a block of 1,251,000 shares of the Company from Artimus Participations at a price of 25.92 euros per share, i.e.
  • at a discount of 2.0 % to today's closing price, representing a total investment of 32.4 million euros.
  • Following the transaction and cancellation of the repurchased shares, Artimus Participations' stake in the Company will be reduced to 5.40 % of the Company's share capital and to 8.36 % of its voting rights.
  • The proceeds from the sale will be used to repay Artimus Participations’ debt.

CMG Cleantech S.A.: Tech Infinite and Turkish miner, Bozdag Komur Isletme Madencilik Enerji Insaat A.S., sign a 20 year Power Purchase Agreement  

Retrieved on: 
Tuesday, September 5, 2023
Conseil, Partnership, International Trade Administration, Falakro, Carbon, Oil States Energy Services, LLC v. Greene's Energy Group, LLC, CMG, Mining, Engineering, Natural Resources, Regulatory News Service, Renewable energy

CMG Cleantech S.A.: Tech Infinite and Turkish miner, Bozdag Komur Isletme Madencilik Enerji Insaat A.S., sign a 20 year Power Purchase Agreement

Key Points: 
  • CMG Cleantech S.A.: Tech Infinite and Turkish miner, Bozdag Komur Isletme Madencilik Enerji Insaat A.S., sign a 20 year Power Purchase Agreement
    Dissemination of a French Regulatory News, transmitted by EQS Group.
  • PARIS, 5 September, 2023 – Tech Infinite Ltd, a subsidiary of the green energy group, CMG CleanTech S.A. (“CMG”) has secured a long-term contract to build a 15 megawatt solar and battery farm for the privately held company Bozdag Komur Isletme Madencilik Enerji Insaat A.S. (“Bozdag”) in Turkey.
  • The 20-year Power Purchase Agreement between Tech Infinite Ltd and Bozdag spans the design, engineering, installation and construction of the solar and battery farm.
  • Turgut Kann Kose, Executive of Bozdag commented, “We are thrilled to be working with CMG CleanTech S.A. and Tech Infinite Ltd.

Lepermislibre: Update of the 2023 financial communication calendar

Retrieved on: 
Tuesday, September 5, 2023
Regulatory News Service, Calendar, Communication

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • Lyon, 05 september 2023 - lePERMISLIBRE, a pioneering online driving school in France, has updated its financial communication calendar for the year 2023.
  • These changes follow lePERMISLIBRE's participation in various financial events.
  • All announced publication dates are after the close of trading.

2CRSi SA: Deferral of the Combined Shareholders’ Meeting of 31 August 2023

Retrieved on: 
Friday, August 11, 2023
Regulatory News Service, ISIN, Sale, Combined, Commercial, Bank statement, Annual report, Security (finance), Cryptocurrency

Strasbourg (France), 11 August 2023 - 2CRSi (ISIN code: FR0013341781), a designer and manufacturer of high-performance, energy-efficient IT servers, announces it is deferring the Combined Shareholders’ Meeting that had been scheduled to take place on 31 August.

Key Points: 
  • Strasbourg (France), 11 August 2023 - 2CRSi (ISIN code: FR0013341781), a designer and manufacturer of high-performance, energy-efficient IT servers, announces it is deferring the Combined Shareholders’ Meeting that had been scheduled to take place on 31 August.
  • For this reason, the company is deferring the Combined Shareholders’ Meeting of 31 August 2023.
  • A notice of deferral will be published on BALO, the French official legal announcements bulletin, on Wednesday, 16 August 2023.
  • The company will inform the market as soon as possible of the new date for the Combined Shareholders’ Meeting.

ABIVAX: NOTICE TO HOLDERS OF BONDS CONVERTIBLE AND/OR EXCHANGEABLE INTO NEW AND/OR EXISTING SHARES (OCEANE) WITH A NOMINAL VALUE OF EUR 24,999,975.99

Retrieved on: 
Wednesday, August 2, 2023
Therapy, CET, EUR, Euronext Paris, Notice, Patient, Immune system, Regulatory News Service, ISIN, Condition, Security (finance)

Dissemination of a French Regulatory News, transmitted by EQS Group.

Key Points: 
  • Dissemination of a French Regulatory News, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • PARIS, France, August 2, 2023 – 06:00 p.m. (CET) – Abivax SA (Euronext Paris: FR0012333284 – ABVX), a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the immune system to treat patients with chronic inflammatory diseases, today published the resetting of the Conversion/Exchange Ratio of convertible Bonds and/or exchangeable into new and/or existing shares (“OCEANE”) due in 2026, with a nominal value of EUR 24,999,975.99 which were issued by Abivax SA (ISIN FR0014004PT4).
  • The number of shares underlying the OCEANE bonds therefore changed from 769,834 to 935,453.